Nautilus Biotechnology Joins ARPA-H-Funded Consortium to Study Alzheimer’s Disease and Cancer
SEATTLE, Washington, United States — October 27, 2026 Nautilus Biotechnology, Inc., a life sciences company developing technologies for high-resolution...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
SEATTLE, Washington, United States — October 27, 2026 Nautilus Biotechnology, Inc., a life sciences company developing technologies for high-resolution...
Basel, Switzerland, August 13, 2026 Genedata, a Danaher company providing enterprise software for biopharmaceutical research and development, has launched...
FREMONT, California, August 10, 2026 Alamar Biosciences, Inc. announced an expansion of its strategic partnership with the Alzheimer’s Disease...
FREMONT, Calif., July 28, 2026 Alamar Biosciences, Inc. has announced the commercial launch of the NULISAseq™ Immune 340 Panel,...
FREMONT, California, July 13, 2026 Alamar Biosciences has partnered with leading U.S. research universities to launch a national-scale proteomics...
MARLBOROUGH, Mass., June 1, 2026 SCIEX, a Danaher company and a global leader in life science analytical technologies, announced...
SOUTH SAN FRANCISCO, California, May 27, 2026 Human Longevity, Inc. (HLI) has announced the creation of Human Life Foundation...
SAN DIEGO, Calif., April 28, 2026 Sapient has announced the launch of its Tumor Protein Mapping Platform, a next-generation...
ST. PAUL, Minn., April 23, 2026 Astrin Biosciences announced that it has received accreditation from the College of American...
Fremont, California, March 17, 2026 Alamar Biosciences, Inc. announced the launch of its NULISAseq™ Neuro 220 Panel, a next-generation...
